Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors

Arca, M

Arca, M (reprint author), Sapienza Univ Roma, Dipartimento Med Interna & Specialita Med, Azienda Policlin Umberto 1 Viale Policlin,155, I-00161 Rome, Italy.

ATHEROSCLEROSIS, 2017; 256 ( ): 134

Abstract

Heterozygous familial hypercholesterolemia (HeFH) is a common (early estimates suggested a prevalence of 1 in 500 individuals, but recent studies have......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索